Guia prático de urticária aguda
Practical guide to acute urticaria
Carolina Tavares de Alcântara; Daniela Farah Teixeira Raeder; Fernanda Lugao Campinhos; Larissa Silva Brandão; Régis de Albuquerque Campos; Alfeu Tavares Franca; Rozana de Fátima Gonçalves; Eli Mansour; Janaina Michelle Lima Melo; Solange Oliveira Rodrigues Valle; Gabriela Andrade Dias; Leila Vieira Borges Trancoso-Neves; Rosana Câmara Agondi; Luis Felipe Chiaverini Ensina
Resumo
A urticária aguda é uma causa frequente de consulta com alergistas, caracterizada por urticas e/ou angioedema. Embora autolimitada e benigna, pode causar desconforto significativo e raramente representar uma doença sistêmica grave ou reação alérgica com risco de vida. Nesta revisão, elaborada pelo Departamento Científico de Urticária da Associação Brasileira de Alergia e Imunologia, foram abordadas as principais questões referentes ao tema para auxiliar o médico especialista e generalista.
Palavras-chave
Abstract
Acute urticaria is a frequent cause of consultations with allergists, being characterized by wheals and/or angioedema. Although self-limited and benign, it may cause significant discomfort and uncommonly represent a serious systemic disease or life-threatening allergic reaction. In this review prepared by the Urticaria Scientific Department of the Brazilian Association of Allergy and Immunology, the main questions about this topic are addressed to help specialists and general practitioners.
Keywords
Referências
1. Ensina LF, Valle SOR, Campos RA, Agondi R, Criado P, Bedrikow RB, et al. Guia prático da Associação Brasileira de Alergia e Imunologia para o diagnóstico e tratamento das urticárias baseado em diretrizes internacionais. Arq Asma Alerg Imunol. 2019;3(4):382-92.
2. Zuberbier T, Abdul Latiff AH, Abuzakouk M, Aquilina S, Asero R, Baker D, et al. The international EAACI/GA²LEN/EuroGuiDerm/ APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2022;77(3):734-66. doi: 10.1111/ all.15090.
3. Minasi D, Manti S, Chiera F, Licari A, Marseglia GL. Acute urticaria in the infant. Pediatr Allergy Immunol. 2020;31(Suppl. 26):49-51.
4. Losappio L, Heffler E, Bussolino C, Cannito CD, Carpentiere R, Raie A, et al. Acute urticaria presenting in the emergency room of a general hospital. Eur J Intern Med. 2014;25(2):147-50.
5. Peroni A, Colato C, Zanoni G, Girolomoni G. Urticarial lesions: if not urticaria, what else? The differential diagnosis of urticaria: part II. Systemic diseases. J Am Acad Dermatol. 2010; 62 (4): 557-70.
6. Pite H, Wedi B, Borrego LM, Kapp A, Raap U. Management of childhood urticaria: current knowledge and practical recommendations. Acta Derm Venereol. 2013;93(5):500-8.
7. Nettis E, Foti C, Ambrifi M, Baiardini I, Bianchi L, Borghi A, et al. Urticaria: recommendations from the Italian Society of Allergology, Asthma and Clinical Immunology and the Italian Society of Allergological, Occupational and Environmental Dermatology. Clin Mol Allergy. 2020;6;18:8.
8. Bernstein JA, Lang DM, Khan DA, Craig T, Dreyfus D, Hsieh F, et al. The diagnosis and management of acute and chronic urticaria: 2014 update. J Allergy Clin Immunol. 2014;133(5):1270-7.
9. Church MK, Kolkhir P, Metz M, Maurer M. The role and relevance of mast cells in urticaria. Immunol Rev. 2018;282(1):232-47.
10. Siebenhaar F, Redegeld FA, Bischoff SC, Gibbs BF, Maurer M. Mast cells as drivers of disease and therapeutic targets. Trends Immunol. 2018;39(2):151-62.
11. Huston DP, Sabato V. Decoding the Enigma of Urticaria and Angioedema. J Allergy Clin Immunol Pract. 2018;6(5):181-2.
12. McNeil BD, Pundir P, Meeker S, Han L, Undem BJ, Kulka M, et al. Identification of a mast cell specific receptor crucial for pseudoallergic drug reactions. Nature. 2015;519:237-41.
13. Ali H. Mas-related G protein coupled receptor-X2: a potential new target for modulating mast cell-mediated allergic and inflammatory diseases. J Immunobiol. 2016;1:115.
14. Azimi E, Reddy VB, Seadi Pereira PJ, Talbot S, Woolf CJ, Lerner EA. Substance P activates Mas-related G protein-coupled receptors to induce itch. J Allergy Clin Immunol. 2017;140:447-53.
15. Jimenez-Rodriguez TW, Garcia-Neuer M, Alenazy LA, Castells M. Anaphylaxis in the 21st century: phenotypes, endotypes, and biomarkers. J Asthma Allergy. 2018;11:121-42.
16. Migeotte I, Communi D, Parmentier M. Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses. Cytokine Growth Factor Rev. 2006;17:501‑19.
17. Davis MDP, Van Der Hilst JCH. Mimickers of Urticaria: Urticarial Vasculitis and Autoinflammatory Diseases. J Allergy Clin Immunol Pract. 2018;6(4):1162-70.
18. Sandig H, Bulfone-Paus S. TRL signaling in mast cells: common and unique features. Front Immunol. 2012;3:1-29.
19. Niyonsaba F, Ushio H, Hara M, Yokoi H, Tominaga M, Takamori K, et al. Antimicrobial peptides human beta-defensins and cathelicidin LL37 induce the secretion of a pruritogenic cytokine IL-31 by human mast cells. J Immunol. 2010;184:3526-34.
20. Maurer M, Zuberbier T, Metz M. The Classification, Pathogenesis, Diagnostic Workup, and Management of Urticaria: An Update. Handb Exp Pharmacol. 2022;268:117-33. doi: 10.1007/164_2021_506.
21. Jares EJ, Sanchez-Borges M, Cardona-Villa R, Ensina LF, Arias-Cruz A, Gómes M, et al. Multinational experience with hypersensitivity drug reactions in Latin America. Ann Allergy Asthma Immunol. 2014;113(3):282-9.
22. Sanchez-Borges M. NSAID hypersensitivity (respiratory, cutaneous, and generalized anaphylactic symptoms). The Medical clinics of North America. 2010;94(4):853-64.
23. Kowalski ML, Woessner K, Sanak M. Approaches to the diagnosis and management of patients with a history of nonsteroidal antiinflammatory drug – related urticaria and angioedema. J Allergy Clin Immun. 2015;136(2):245-51.
24. Cunha FS, Mambriz APM, Araujo CA, Lacerda AE, Ensina LF, et al. Tolerância ao paracetamol em crianças com hipersensibilidade não seletiva aos anti-inflamatórios não esteroidais. Arq Asma Alerg Imunol. 2019;3(2):163-7.
25. Andreozzi L, Giannetti A, Cipriani F, Caffarelli C, Mastrorilli C, Ricci G. Hypersensitivity reactions to food and drug additives: problem or myth? Acta Biomed. 2019;90(3-S):80-90.
26. Pier J, Bingemann TA. Urticaria, Angioedema, and Anaphylaxis. Pediatr Rev. 2020;41(6):283-92.
27. Imbalzano E, Casciaro M, Quartuccio S, Minciullo PL, Cascio A, Calapai G, et al. Association between urticaria and virus infections: A systematic review. Allergy Asthma Proc. 2016;37(1):18-22.
28. Techasatian L, Phungoen P, Chaiyarit J, Uppala R. Etiological and predictive factors of pediatric urticaria in an emergency context. BMC Pediatr. 2021;21(1):92.
29. Minciullo PL, Cascio A, Barberi G, Gangemi S. Urticaria and bacterial infections. Allergy Asthma Proc. 2014;35(4):295-302.
30. Schaefer P. Acute and Chronic Urticaria: Evaluation and Treatment. Am Fam Physician. 2017;95(11):717-24.
31. Sánchez-Borges M, Asero R, Ansotegui IJ, Baiardini I, Bernstein JA, Canonica GW, et al.; WAO Scientific and Clinical Issues Council. Diagnosis and treatment of urticaria and angioedema: a worldwide perspective. World Allergy Organ J. 2012;5(11):125-47.
32. Liu TH, Lin YR, Yang KC, Tsai YG, Fu YC, Wu TK, et al. Significant factors associated with severity and outcome of an initial episode of acute urticaria in children. Pediatr Allergy Immunol. 2010;21(7):1043‑51.
33. Maltsev SV, Sizyakina LP, Lebedenko AA. The role of transcription factor FoxP3 as a predictor of acute and chronic urticaria in children. Medical Herald of the South of Russia. 2021;12(3):50-4.
34. Abella BS, Berger WE, Blaiss MS, Stiell IG, Herres JP, Moellman JJ, et al. Intravenous Cetirizine Versus Intravenous Diphenhydramine for the Treatment of Acute Urticaria: A Phase III Randomized Controlled Noninferiority Trial. Ann Emerg Med. 2020;76(4):489-500.
35. Comert S, Celebioglu E, Karakaya G, Kalyoncu AF. The general characteristics of acute urticaria attacks and the factors predictive of progression to chronic urticaria. Allergol Immunopath. 2013;41(4):239-45.
36. Magen E, Zueva E, Mishal J, Schlesinger M. The clinical and laboratory characteristics of acute spontaneous urticaria and its progression to chronic spontaneous urticaria. Allergy Asthma Proc. 2016;37(5):394-9.
37. Cetinkaya PG, Soyer O, Esenboga S, Sahiner UM, Teksam O, Sekerel BE. Predictive factors for progression to chronicity or recurrence after the first attack of acute urticaria in preschool-age children. Allergol Immunopath. 2019;47(5):484-90.
Submetido em:
26/02/2022
Aceito em:
06/03/2022
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email